
The episode discusses the evolution of women's health into a mainstream industry priority and explores the opportunities and challenges within this space.
Why is now the moment for women's health? On this episod e , Epstein Becker Green attorneys Rachel Snyder Good , Beth Scarola , and Laura DePonio sit down with Sheila Biggs , Vice President of Jarrard , to explore how women's health is evolving from a niche focus into a mainstream industry priority. They discuss the forces accelerating growth, the opportunities for change, and the challenges that still need to be addressed across outcomes, access, and patient experience. This episode unpacks several key topics, including: what "women's health" really means today—far beyond fertility and reproductive care; how decades of underinvestment created new opportunities for innovation, equity, and growth; why investors and policymakers are turning their attention to this space, and what's driving the momentum; the biggest gaps still to close in outcomes, access, and patient experience; how storytelling and strategy can help reshape the public narrative around women's health; and where the industry is headed next —including insights related to the upcoming Women's Health Innovation Summit. Visit our site for related resources and email contact information: https://www.ebglaw.com/dhc90…
Hosts: Rachel Snyder Good, Beth Scarola, Laura DePonio
Guest: Sheila Biggs
Organizations: Jarrard, Epstein Becker Green, Women's Health Innovation Summit
Explore listener stats, chart rankings, contacts and more on the Diagnosing Health Care Podcast podcast page.